ARCHIVES

Congressional Panel Is Investigating FDA Oversight Of Generic Cancer Drugs

This article is from The Cancer Letter archive.

Vol. 21 No. 33 | August 18, 1995

Download PDF Visit The Full Archive

Related Articles

Unwanted Distinction: MSKCC Bars Zaltrap From Formulary, Triggering Debate Over Drug Pricing

November 1, 2012

Adriamycin Fact Sheet Available

July 4, 1975

Cancer Incidence, Mortality Rates Trend Downward, NCI, ACS Say In “Report Card”

March 13, 1998

Centers Urged To Apply For Comprehensive Status By June 1

February 16, 1990

Komen Under Pressure: Charity Faces Money Woes, Attacks from Right

October 26, 2012

In Brief: Treatment Reorganization Will Give Rauscher “Lumps,” He Says; Coordinating Group Favored

August 16, 1974